Samira Jaeger

483 total citations
17 papers, 330 citations indexed

About

Samira Jaeger is a scholar working on Molecular Biology, Computational Theory and Mathematics and Cancer Research. According to data from OpenAlex, Samira Jaeger has authored 17 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Computational Theory and Mathematics and 5 papers in Cancer Research. Recurrent topics in Samira Jaeger's work include Computational Drug Discovery Methods (6 papers), Bioinformatics and Genomic Networks (6 papers) and Click Chemistry and Applications (2 papers). Samira Jaeger is often cited by papers focused on Computational Drug Discovery Methods (6 papers), Bioinformatics and Genomic Networks (6 papers) and Click Chemistry and Applications (2 papers). Samira Jaeger collaborates with scholars based in Germany, Spain and United Kingdom. Samira Jaeger's co-authors include Patrick Aloy, Ulf Leser, Miquel Duran‐Frigola, Sylvain Gaudan, Dietrich Rebholz‐Schuhmann, Ángel R. Nebreda, Modesto Orozco, Begoña Cánovas, Ana Igea and Víctor Alcalde and has published in prestigious journals such as Nature Communications, Blood and PLoS ONE.

In The Last Decade

Samira Jaeger

15 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Samira Jaeger Germany	9	237	77	32	30	26	17	330
Buğra Özer Türkiye	8	237 1.0×	56 0.7×	58 1.8×	9 0.3×	25 1.0×	16	346
Panuwat Trairatphisan Germany	10	264 1.1×	86 1.1×	22 0.7×	22 0.7×	9 0.3×	19	361
Prisca Lo Surdo Italy	8	255 1.1×	60 0.8×	24 0.8×	23 0.8×	7 0.3×	12	340
Yubo Fan United States	6	206 0.9×	29 0.4×	35 1.1×	24 0.8×	6 0.2×	9	309
Sue Povey United Kingdom	4	301 1.3×	26 0.3×	40 1.3×	19 0.6×	9 0.3×	4	432
Maruan Hijazi United Kingdom	8	194 0.8×	57 0.7×	30 0.9×	11 0.4×	26 1.0×	12	257
Elizabeth A. Coker United Kingdom	7	286 1.2×	108 1.4×	101 3.2×	21 0.7×	9 0.3×	13	385
Ioannis N. Melas Greece	11	282 1.2×	117 1.5×	34 1.1×	49 1.6×	10 0.4×	24	410
Oliver Sturm United Kingdom	6	427 1.8×	67 0.9×	78 2.4×	53 1.8×	7 0.3×	6	565
Valentine Rech de Laval Switzerland	6	297 1.3×	20 0.3×	26 0.8×	28 0.9×	7 0.3×	8	364

Countries citing papers authored by Samira Jaeger

Since Specialization

Citations

This map shows the geographic impact of Samira Jaeger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samira Jaeger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samira Jaeger more than expected).

Fields of papers citing papers by Samira Jaeger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samira Jaeger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samira Jaeger. The network helps show where Samira Jaeger may publish in the future.

Co-authorship network of co-authors of Samira Jaeger

This figure shows the co-authorship network connecting the top 25 collaborators of Samira Jaeger. A scholar is included among the top collaborators of Samira Jaeger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samira Jaeger. Samira Jaeger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Sanborn, Rachel E., Minal Patel, Jordi Rodón, et al.. (2024). 991O First-in-human (FIH) phase I data of HST-1011, an oral CBL-B inhibitor, in patients with advanced solid tumors. Annals of Oncology. 35. S675–S676. 1 indexed citations

Qi, Yilin, Jun Kuai, Yingzhi Bi, et al.. (2023). Abstract LB337: Inhibition of the E3 ligase CBL-B enhances the effector function and proliferation of natural killer cells. Cancer Research. 83(8_Supplement). LB337–LB337. 1 indexed citations

Yao, Yi, Yingzhi Bi, Jun Kuai, et al.. (2023). Discovery of Novel, First-in-Class Allosteric Modulators of MALT1 Scaffolding Function with Differentiated Pharmacology for NFκB-Driven Malignancies. Blood. 142(Supplement 1). 52–52. 2 indexed citations

Qi, Yilin, Jun Kuai, Yingzhi Bi, et al.. (2022). 424 An allosteric, orally administered CBL-B inhibitor remodels the tumor microenvironment and enhances immune-mediated tumor growth inhibition. Regular and Young Investigator Award Abstracts. A445–A445.

Hennrich, Marco L., Natalie Romanov, Patrick Horn, et al.. (2018). Cell-specific proteome analyses of human bone marrow reveal molecular features of age-dependent functional decline. Nature Communications. 9(1). 4004–4004. 63 indexed citations

Schlereth, Katharina, Dieter Weichenhan, Tobias Bauer, et al.. (2018). The transcriptomic and epigenetic map of vascular quiescence in the continuous lung endothelium. eLife. 7. 38 indexed citations

Jaeger, Samira, Ana Igea, Víctor Alcalde, et al.. (2016). Quantification of Pathway Cross-talk Reveals Novel Synergistic Drug Combinations for Breast Cancer. Cancer Research. 77(2). 459–469. 64 indexed citations

Ho, Anthony D., Patrick Horn, Marco L. Hennrich, et al.. (2016). Proteomics Analysis of Cellular Network in Human Bone Marrow Reveals Lineage Skewing Towards Megakaryocytes and Decrease in Lymphoid Development upon Aging. Blood. 128(22). 2658–2658.

Jaeger, Samira, Miquel Duran‐Frigola, & Patrick Aloy. (2015). Drug sensitivity in cancer cell lines is not tissue-specific. Molecular Cancer. 14(1). 40–40. 37 indexed citations

10.

Haid, A., et al.. (2015). P058 Comparison of EndoPredict and MammaPrint in hormone receptor positive, HER2 negative breast cancer. The Breast. 24. S46–S47. 1 indexed citations

11.

Jaeger, Samira & Patrick Aloy. (2012). From protein interaction networks to novel therapeutic strategies. IUBMB Life. 64(6). 529–537. 37 indexed citations

12.

Starlinger, Johannes, et al.. (2011). PiPa: custom integration of protein interactions and pathways. GI-Jahrestagung. 158. 2 indexed citations

13.

Jaeger, Samira, Christine Sers, & Ulf Leser. (2010). Combining modularity, conservation, and interactions of proteins significantly increases precision and coverage of protein function prediction. BMC Genomics. 11(1). 717–717. 12 indexed citations

14.

Jaeger, Samira, Gökhan Ertaylan, David van Dijk, Ulf Leser, & P.M.A. Sloot. (2010). Inference of Surface Membrane Factors of HIV-1 Infection through Functional Interaction Networks. PLoS ONE. 5(10). e13139–e13139. 5 indexed citations

15.

Jaeger, Samira, Sylvain Gaudan, Ulf Leser, & Dietrich Rebholz‐Schuhmann. (2008). Integrating protein-protein interactions and text mining for protein function prediction. BMC Bioinformatics. 9(S8). S2–S2. 34 indexed citations

16.

Jaeger, Samira & Ulf Leser. (2007). High-Precision Function Prediction using Conserved Interactions.. 146–162. 8 indexed citations

17.

Dix, Trevor I., et al.. (2007). Comparative analysis of long DNA sequences by per element information content using different contexts. BMC Bioinformatics. 8(S2). S10–S10. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact